Editor’s Note: Ten out of 14 evaluators rated this product 4.5-5.0. Four evaluators rated this product 2.0-3.5. This means that most (71%) evaluators were very impressed with this product, but a sizable minority (29%) were not convinced that its benefits outweighed its risks.
